USE OF OXALIPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): A POST-HOC ANALYSIS OF THE GLUTOX STUDY

被引：0
|
作者：
Benoit, Samson [1 ]
Pierre, Dube [2 ]
Nathalie, Aucoin [3 ]
Rafal, Wierzbicki [4 ]
Jean, Maroun [5 ]
Richard, Letourneau [6 ]
Eric, Chen [7 ]
Danielle, Charpentier [8 ]
Felix, Couture [9 ]
Mark, Vincent [10 ]
Jean, Lepine [11 ]
Pierre, Whitlock [12 ]
Karine, Alloul [13 ]
Francois, Leblond [13 ]
Wei, Zhou [13 ]
Petr, Kavan [14 ]
机构：
[1] Ctr Sante & Serv Sociaux Champlain Charles Lemoyn, Greenfield Pk, PQ, Canada
[2] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
[3] Hop Cite de la Sante, Laval, PQ, Canada
[4] RSM Durham Reg Canc Ctr, Oshawa, ON, Canada
[5] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[6] CHUM Hop St Luc, Montreal, PQ, Canada
[7] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[8] CHUM Hop Notre Dame, Montreal, PQ, Canada
[9] CHUQ Pavillon Hotel Dieu Quebec, Quebec City, PQ, Canada
[10] London Hlth Sci Ctr, London, ON, Canada
[11] Ctr Hosp Reg Rimouski, Rimouski, PQ, Canada
[12] Dr Leon Richard Oncol Ctr, Moncton, NB, Canada
[13] Sanofi Canada, Laval, PQ, Canada
[14] McGill Univ, Montreal, PQ, Canada
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu165.209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 0214
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels
    Ng, Say Liang
    Burns, William I.
    Snyder, Raymond D.
    Newnham, Genni M.
    Mclachlan, Sue-Anne
    Liew, Danny
    Dowling, Anthony J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (02) : 172 - 179
  • [22] Role of Calcium/Magnesium Infusion in Oxaliplatin-Based Chemotherapy for Colorectal Cancer Patients
    Kurniali, Peter C.
    Luo, Lu Guang
    Weitberg, Alan B.
    ONCOLOGY-NEW YORK, 2010, 24 (03): : 289 - 292
  • [23] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    L Paré-Brunet
    A Sebio
    J Salazar
    A Berenguer-Llergo
    E Río
    A Barnadas
    M Baiget
    D Páez
    The Pharmacogenomics Journal, 2015, 15 : 397 - 404
  • [24] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Pare-Brunet, L.
    Sebio, A.
    Salazar, J.
    Berenguer-Llergo, A.
    Rio, E.
    Barnadas, A.
    Baiget, M.
    Paez, D.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (05): : 397 - 404
  • [25] Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
    Yamamoto, Seiji
    Fujii, Hironori
    Murayama, Kotaro
    Iihara, Hirotoshi
    Watanabe, Daichi
    Yamada, Yunami
    Kobayashi, Ryo
    Kiyama, Shigeru
    Makiyama, Akitaka
    Urano, Kimihiko
    Matsuhashi, Nobuhisa
    Matsuura, Katsuhiko
    Suzuki, Akio
    ANTICANCER RESEARCH, 2023, 43 (11) : 5099 - 5105
  • [26] Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study
    Kato, Shunsuke
    Imai, Hiroo
    Gamoh, Makio
    Takahata, Takenori
    Ohori, Hisatsugu
    Yasuda, Katsuhiro
    Niitani, Tomohito
    Murakawa, Yasuko
    Amagai, Kenji
    Isobe, Hideki
    Shindo, Yoshiaki
    Kuroki, Michio
    Sakamoto, Yasuhiro
    Shimodaira, Hideki
    Yoshioka, Takashi
    Ishioka, Chikashi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 245 (01): : 21 - 28
  • [27] Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 319 - 329
  • [28] Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy for metastatic colorectal cancer.
    Rubbia-Brandt, L
    Audard, V
    Sartoretti, P
    Roth, AD
    Brezault, C
    Lecharpentier, M
    Dousset, B
    Morel, P
    Soubrane, O
    Chaussade, S
    Mentha, G
    Terris, B
    HEPATOLOGY, 2003, 38 (04) : 696A - 696A
  • [29] Oxaliplatin reintroduction in patients pretreated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer (MCRC).
    Maindrault-Goebel, F
    Louvet, C
    André, T
    Carola, E
    Gilles, V
    Garcia, M
    Lotz, JP
    Izrael, V
    Krulik, M
    de Gramont, A
    ANNALS OF ONCOLOGY, 2000, 11 : 50 - 50
  • [30] The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis
    Zhou, Li-Na
    Feng, Chun-Xia
    Zhang, Yan
    Li, Ping
    Tang, Min
    Chen, Min-Bin
    Jin, Jun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (03) : 1086 - 1096
12345